San Diego, CA, United States of America

Sarvjeet S Bindra

This inventor holds 14 USPTO granted patents and 1 published patent application. Top assignee: Fibro Source U.s.a. Inc.. Active years: 2012-2019.

USPTO Granted Patents = 14 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
14 patents (USPTO):Explore Patents

**Title: Innovations of Sarvjeet S. Bindra in the Field of Writing Instruments**

Introduction

Sarvjeet S. Bindra, an accomplished inventor based in San Diego, CA, has made significant contributions to the world of writing instruments. With a remarkable portfolio of 14 patents, he has demonstrated his innovative spirit and commitment to advancing technology in this niche area.

Latest Patents

Among his latest innovations, Sarvjeet has focused on developing enhanced writing instruments that incorporate unique features aimed at improving the user experience. His inventions not only showcase creativity but also address functionality and practicality for everyday use.

Career Highlights

Currently, Sarvjeet S. Bindra is associated with Fibro Source U.S.A. Inc., where he continues to push the boundaries of innovation in writing technology. His role in the company allows him to collaborate with fellow inventors and engineers while honing his skills in product development.

Collaborations

Throughout his career, Bindra has engaged in various collaborations with other inventors and research institutions to further refine his inventions. His cooperative efforts have often resulted in cross-pollination of ideas, leading to the creation of patents that elevate writing instruments to new heights.

Conclusion

In summary, Sarvjeet S. Bindra stands out as an inventive force in the field of writing instruments. His extensive patent portfolio and ongoing contributions at Fibro Source U.S.A. Inc. reflect his dedication to innovation and the future of this essential product.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…